Testimony

Testimony in favor of SB 868 Prescribing and Dispensing Naloxone to Non-certificate Holders

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 16, 2017.

Testimony in favor for HB 909 Maryland Health Insurance Coverage Protection Act

Following is testimony given by Legislative Director Jeff Amoros. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 10, 2017.

Testimony in favor for SB 669 Tobacco Products - Minimum Age and Civil Fines

Following is testimony given by Emilie Gilde, Director of Tobacco Use and Cardiovascular Disease Prevention. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 9, 2017.

Testimony in favor of SB 988 Maryland Community Health Worker Act

Following is testimony given by Margret Schnitzer, Director of the Community Asthma Program. The statement was presented to the Education, Health, and Environmental Affairs on behalf of Dr. Wen on March 9, 2017.

Testimony in Favor of Co-Prescribing Naloxone Saves Lives Act of 2017

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 1, 2017.

Testimony in Favor of HB 1329 Heroin and Opioid Prevention Effort (HOPE) and Treatment Act of 2017

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 7, 2017.

Testimony in Favor of SB415 for Prescription Drug Affordability

Following testimony was provided by Dr. Leana Wen, Baltimore City Commissioner of Health, to the Finance Committee on February 15, 2017.

Testimony in Favor of HB001/SB230 for Paid Sick Leave

Following is testimony given by Dr. Leana Wen, Baltimore City Health Commissioner, presented to the Economic Matters Committee on February 10, 2017.

Testimony in Favor of HB 613 to Permit Licensed Pharmacists to Prescribe and Dispense Contraceptives

Following is testimony given by Rebecca Dineen, Deputy Commissioner of Maternal and Child Health. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on February 10, 2017.

Testimony in Favor of SB 119 to Require Licensing for E-cigarettes

Following is testimony given by Emilie Gilde, Director of Tobacco Use and Cardiovascular Disease Prevention. The statement was presented to the Business Regulation and Occupations Committee on behalf of Dr. Wen on February 1, 2017.

Pages